The Vice President, Clinical Development, Amyloidosis & Rare Cardiology will be a seasoned industry leader with primary responsibility for guiding and executing the strategic direction of development products and programs within Alexion’s Amyloidosis & Rare Cardiology franchise across all stages of development. The incumbent will implement clinical trial execution through strong leadership and collaboration with corporate functions and key internal departments, with accountability for the full scope of clinical development functions from post-PoC to BLA / NDA / MAA in accordance with the Company’s R&D Strategy. This individual will provide strategy and leadership from the perspectives of effective and efficient development and will foster productive, collaborative relationships and work closely with core team members, functional leads and other colleagues to ensure their buy-in and knowledge-sharing in establishing and implementing the global development strategy for assigned projects. productive, interactive relationships. This individual will also be instrumental in defining drug development priorities and in serving as primary resource for all clinical activities, broadening the clinical platform and driving the clinical development of Alexion’s Amyloidosis & Rare Cardiology pipeline through anticipated rapid growth. This is a hands-on position that is expected to deliver top quality development activities in a timely manner.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees